In this study, we have utilized the Chou-Talalay method [23] to examine the question of whether inhibitors of the mTOR and PI3K pathways synergize with ERK pathway inhibitors in their effects on breast cancer cell lines. The gene discussed is MTOR; the disease is breast cancer.